These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36916178)

  • 1. Pilot study: External surface contamination of gemcitabine and 5-fluorouracil on drug packaging.
    Kåredal M; Özdemir J; Tinnert A; Wetterling M; Hedmer M
    J Oncol Pharm Pract; 2024 Jan; 30(1):9-14. PubMed ID: 36916178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External contamination of antineoplastic drug vials: an occupational risk to consider.
    Cotteret C; Secretan PH; Gilles-Afchain L; Rousseau J; Vidal F; Salguero-Hernandez G; Batista J; Valverde V; Guitton J; Cisternino S; Schlatter J
    Eur J Hosp Pharm; 2022 Sep; 29(5):284-286. PubMed ID: 32978219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project.
    Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D
    Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels and risks of surface contamination by thirteen antineoplastic drugs in the Czech and Slovak hospitals and pharmacies.
    Doležalová L; Bláhová L; Kuta J; Hojdarová T; Kozáková Š; Bláha L
    Environ Sci Pollut Res Int; 2022 Apr; 29(18):26810-26819. PubMed ID: 34855176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleaning Efficiencies of Three Cleaning Agents on Four Different Surfaces after Contamination by Gemcitabine and 5-fluorouracile.
    Böhlandt A; Groeneveld S; Fischer E; Schierl R
    J Occup Environ Hyg; 2015; 12(6):384-92. PubMed ID: 25751496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet.
    Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y
    J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual contamination in antineoplastic drug packaging.
    E Silva LS; Machado CDSB; Linden R; Antunes MV; da Silva LC; Wayhs CAY; Capp E; Ness SLR
    J Oncol Pharm Pract; 2023 Dec; 29(8):1862-1867. PubMed ID: 36659825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market.
    Fleury-Souverain S; Nussbaumer S; Mattiuzzo M; Bonnabry P
    J Oncol Pharm Pract; 2014 Apr; 20(2):100-11. PubMed ID: 23676511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics.
    Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C
    J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External contamination of commercial containers by antineoplastic agents: a literature review.
    Hilliquin D; Tanguay C; Bussières JF
    Eur J Hosp Pharm; 2020 Sep; 27(5):313-314. PubMed ID: 32839267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination.
    Touzin K; Bussières JF; Langlois E; Lefebvre M; Gallant C
    Ann Occup Hyg; 2008 Nov; 52(8):765-71. PubMed ID: 18663228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide- and ifosfamide-contaminated surfaces.
    Mucci N; Dugheri S; Farioli A; Garzaro G; Rapisarda V; Campagna M; Bonari A; Arcangeli G
    Med Pr; 2020 Sep; 71(5):519-529. PubMed ID: 32667290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of long-term data on surface contamination by antineoplastic drugs in pharmacies.
    Quartucci C; Rooney JPK; Nowak D; Rakete S
    Int Arch Occup Environ Health; 2023 Jul; 96(5):675-683. PubMed ID: 36877242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational Exposure Assessment to Antineoplastic Drugs in Nine Italian Hospital Centers over a 5-Year Survey Program.
    Sottani C; Grignani E; Cornacchia M; Negri S; Cuna FSRD; Cottica D; Bruzzese D; Severi P; Strocchi D; Verna G; Leso V; Iavicoli I
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
    Werumeus Buning A; Geersing TH; Crul M
    Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.